# Surveillance for Early Liver Injuries Caused by Xianlin Gubao Capsule.

> **NCT03091244** · — · UNKNOWN · sponsor: **Beijing 302 Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Drug-Induced Liver Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03091244
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-25
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03091244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03091244, "Surveillance for Early Liver Injuries Caused by Xianlin Gubao Capsule.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03091244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*